In patients with active or chronic thyroid eye disease, veligrotug improved symptoms of proptosis and diplopia and clinical ...

DVLA guidance focuses on a shorter list of notifiable eye conditions than it once did, as the previous one could have applied ...

In THRIVE, Abrams' group recruited participants with moderate-to-severe active thyroid eye disease with proptosis at least 3 ...